The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
作者:
主题词
醇氧化还原酶类(Alcohol Oxidoreductases);动物(Animals);细胞凋亡(Apoptosis);乳腺肿瘤(Breast Neoplasms);细胞周期(Cell Cycle);细胞系, 肿瘤(Cell Line, Tumor);细胞运动(Cell Movement);细胞存活(Cell Survival);DNA结合蛋白质类(DNA-Binding Proteins);疾病恶化(Disease Progression);抗药性, 肿瘤(Drug Resistance, Neoplasm);上皮-间质转化(Epithelial-Mesenchymal Transition);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);小鼠(Mice);小鼠, 裸(Mice, Nude);微RNAs(MicroRNAs);突变(Mutation);肿瘤转移(Neoplasm Metastasis);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤移植(Neoplasm Transplantation);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53)
DOI
10.18632/oncotarget.10489
PMID
27409664
发布时间
2018-11-13
- 浏览29

Oncotarget
49859-49877页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文